Science

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

Daniel M. Libby

Dec 25, 2024, 09:42

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

Clinical Lung Cancer shared an article by Daniel M. Libby on X:

“Explore a new article evaluating the association of oncogene driver mutations with recurrence and survival in stage I non-small cell lung cancer (NSCLC).”

Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Non-small Cell Lung Cancer.

Authors: Daniel M. Libby, et al.

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

cancer Clinical Lung Cancer Daniel M. Libby fight against cancer Global fight against cancer non small cell lung cancer NSCLC OncoDaily oncogene Oncology

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC